266 related articles for article (PubMed ID: 2529311)
1. Low molecular weight B cell growth factor-responsive cloned human B cell lines. I. Phenotypic differences and lack of requirement for CD23 (Fc epsilon RII).
Warrington RJ; Rutherford WJ; Wong SK; Cook JM; Rector ES
J Immunol; 1989 Oct; 143(8):2546-52. PubMed ID: 2529311
[TBL] [Abstract][Full Text] [Related]
2. Allergen-directed expression of Fc receptors for IgE (CD23) on human T lymphocytes is modulated by interleukin 4 and interferon-gamma.
Prinz JC; Baur X; Mazur G; Rieber EP
Eur J Immunol; 1990 Jun; 20(6):1259-64. PubMed ID: 2142456
[TBL] [Abstract][Full Text] [Related]
3. IL-6 augments Fc IgE receptor (Fc epsilon RII/CD23) expression on human monoblastic/monocytic cell lines U937, THP-1, and Mono-Mac-6 but not on blood monocytes. Regulatory effects of IL-4 and IFN-gamma.
Willheim M; Gessl A; Berger R; Schedle A; Luger T; Föster O; Boltz-Nitulescu G
J Immunol; 1991 Sep; 147(6):1837-42. PubMed ID: 1832425
[TBL] [Abstract][Full Text] [Related]
4. Expression of CD23 antigen is not necessary for human 12-kDa B cell growth factor-mediated B cell proliferation.
Vazquez A; Mills S; Sharma S; Maizel AL
Eur J Immunol; 1988 Oct; 18(10):1647-9. PubMed ID: 2973416
[TBL] [Abstract][Full Text] [Related]
5. Cross-linking of CD23 antigen by its natural ligand (IgE) or by anti-CD23 antibody prevents B lymphocyte proliferation and differentiation.
Luo HY; Hofstetter H; Banchereau J; Delespesse G
J Immunol; 1991 Apr; 146(7):2122-9. PubMed ID: 1826018
[TBL] [Abstract][Full Text] [Related]
6. Functional studies examining the subpopulation of human B lymphocytes responding to high molecular weight B cell growth factor.
Ambrus JL; Chesky L; Stephany D; McFarland P; Mostowski H; Fauci AS
J Immunol; 1990 Dec; 145(12):3949-55. PubMed ID: 2258603
[TBL] [Abstract][Full Text] [Related]
7. Regulation of Fc receptor for IgE (CD23) and class II MHC antigen expression on Burkitt's lymphoma cell lines by human IL-4 and IFN-gamma.
Rousset F; Malefijt RW; Slierendregt B; Aubry JP; Bonnefoy JY; Defrance T; Banchereau J; de Vries JE
J Immunol; 1988 Apr; 140(8):2625-32. PubMed ID: 2965726
[TBL] [Abstract][Full Text] [Related]
8. IFN-gamma and prostaglandin E2 inhibit IL-4-induced expression of Fc epsilon R2/CD23 on B lymphocytes through different mechanisms without altering binding of IL-4 to its receptor.
Galizzi JP; Cabrillat H; Rousset F; Ménétrier C; de Vries JE; Banchereau J
J Immunol; 1988 Sep; 141(6):1982-8. PubMed ID: 2844892
[TBL] [Abstract][Full Text] [Related]
9. B cell growth and differentiation factors interact with receptors distinct from the interleukin 2 receptor.
Kehrl JH; Grove JH; Goldsmith PK; Fauci AS
Eur J Immunol; 1986 Jul; 16(7):761-6. PubMed ID: 3013645
[TBL] [Abstract][Full Text] [Related]
10. Leukotriene B4 potentiates the expression and release of Fc epsilon RII/CD23, and proliferation and differentiation of human B lymphocytes induced by IL-4.
Dugas B; Paul-Eugene N; Cairns J; Gordon J; Calenda A; Mencia-Huerta JM; Braquet P
J Immunol; 1990 Nov; 145(10):3406-11. PubMed ID: 2172383
[TBL] [Abstract][Full Text] [Related]
11. Influence of recombinant IL-4, IFN-alpha, and IFN-gamma on the production of human IgE-binding factor (soluble CD23).
Delespesse G; Sarfati M; Peleman R
J Immunol; 1989 Jan; 142(1):134-8. PubMed ID: 2521231
[TBL] [Abstract][Full Text] [Related]
12. The marmoset B-lymphoblastoid cell line (B95-8) produces and responds to B-cell growth and differentiation factors: role of shed CD23 (sCD23).
Callard RE; Lau YL; Shields JG; Smith SH; Cairns J; Flores-Romo L; Gordon J
Immunology; 1988 Nov; 65(3):379-84. PubMed ID: 3145248
[TBL] [Abstract][Full Text] [Related]
13. Development and characterization of a human B cell line that responds to B cell growth factor but not interleukin 2.
Tseng CT; Springgate CF; Piela TH; Choi YS
J Immunol; 1987 Apr; 138(8):2554-60. PubMed ID: 3031160
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of interleukin 4-promoted CD23 production in human B lymphocytes by transforming growth factor-beta, interferons or anti-CD19 antibody is overriden on engaging CD40.
Gordon J; Katira A; Strain AJ; Gillis S
Eur J Immunol; 1991 Aug; 21(8):1917-22. PubMed ID: 1714394
[TBL] [Abstract][Full Text] [Related]
15. CD19 regulation of human B cell responses. B cell proliferation and antibody secretion are inhibited or enhanced by ligation of the CD19 surface glycoprotein depending on the stimulating signal used.
Callard RE; Rigley KP; Smith SH; Thurstan S; Shields JG
J Immunol; 1992 May; 148(10):2983-7. PubMed ID: 1374445
[TBL] [Abstract][Full Text] [Related]
16. Induction of Fc epsilon RII/CD23 on phytohemagglutinin-activated human peripheral blood T lymphocytes. I. Enhancement by IL-2 and IL-4.
Kawabe T; Maekawa N; Maeda Y; Hosoda M; Yodoi J
J Immunol; 1991 Jul; 147(2):548-53. PubMed ID: 1830067
[TBL] [Abstract][Full Text] [Related]
17. Effect of interferon-alpha on the expression and release of the CD23 molecule in hairy cell leukemia.
Genot E; Sarfati M; Sigaux F; Petit-Koskas E; Billard C; Mathiot C; Falcoff E; Delespesse G; Kolb JP
Blood; 1989 Nov; 74(7):2455-63. PubMed ID: 2529929
[TBL] [Abstract][Full Text] [Related]
18. Recombinant soluble Fc epsilon receptor II (Fc epsilon RII/CD23) has IgE binding activity but no B cell growth promoting activity.
Uchibayashi N; Kikutani H; Barsumian EL; Hauptmann R; Schneider FJ; Schwendenwein R; Sommergruber W; Spevak W; Maurer-Fogy I; Suemura M
J Immunol; 1989 Jun; 142(11):3901-8. PubMed ID: 2523938
[TBL] [Abstract][Full Text] [Related]
19. Evidence for an association between CD23 and the receptor for a low molecular weight B cell growth factor.
Gordon J; Webb AJ; Walker L; Guy GR; Rowe M
Eur J Immunol; 1986 Dec; 16(12):1627-30. PubMed ID: 3028819
[TBL] [Abstract][Full Text] [Related]
20. Immune dysfunction in mice with plasmacytomas. I. Evidence that transforming growth factor-beta contributes to the altered expression of activation receptors on host B lymphocytes.
Berg DJ; Lynch RG
J Immunol; 1991 Apr; 146(8):2865-72. PubMed ID: 1826699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
